NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

DBV Technologies S.A (OTCGREY: DBVTF)

 
DBVTF Technical Analysis
1
As on N/A DBVTF STOCK Price closed @ N/A and we RECOMMEND N/A for LONG-TERM with Stoploss of N/A & N/A for SHORT-TERM with Stoploss of N/A we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

DBVTFSTOCK Price

Open N/A Change Price %
High N/A 1 Day N/A N/A
Low N/A 1 Week N/A N/A
Close N/A 1 Month N/A N/A
Volume N/A 1 Year N/A N/A
52 Week High N/A | 52 Week Low N/A
 
OTCGREY USA Most Active Stocks
FLYE 5.79 %
XANAF 0.04 -33.33%
RTTGF 0.02 0.00%
IARED 24.62 %
CVMCA 22.54 -0.75%
JRVMF 0.01 0.00%
GCEA 29.00 -21.20%
AHLD 82.75 -2.93%
BOVNF 3.29 -30.00%
MAXC 1.78 0.00%
 
OTCGREY USA Top Gainers Stocks
MSGNF 0.21 2000.00%
QIFTF 0.58 1060.00%
CBVTF 0.09 800.00%
WSKEF 15.60 547.30%
GPACF 0.25 400.00%
GPACF 0.25 400.00%
PFGTF 0.10 400.00%
ADXDF 0.01 200.00%
ADXDF 0.01 200.00%
YNAJF 2.39 191.46%
 
OTCGREY USA Top Losers Stocks
PTHIF 0.07 -90.91%
PTHIF 0.07 -90.91%
GENPF 0.12 -75.00%
GENPF 0.12 -75.00%
DRVYF 0.01 -75.00%
TNSTF 0.01 -66.67%
FUUN 0.01 -66.67%
FMZNF 0.19 -62.00%
GGLXF 0.04 -60.00%
NXFNF 5.34 -59.14%
 
 
DBVTF
Daily Charts
DBVTF
Intraday Charts
Whats New @
Bazaartrend
DBVTF
Free Analysis
 
DBVTF Important Levels Intraday
RESISTANCE
RESISTANCE
RESISTANCE
RESISTANCE
RESISTANCE
RESISTANCE
RESISTANCE
RESISTANCE
 
DBVTF Forecast July 2025
4th UP Forecast
3rd UP Forecast
2nd UP Forecast
1st UP Forecast
1st DOWN Forecast
2nd DOWN Forecast
3rd DOWN Forecast
4th DOWN Forecast
 
DBVTF Weekly Forecast
4th UP Forecast
3rd UP Forecast
2nd UP Forecast
1st UP Forecast
1st DOWN Forecast
2nd DOWN Forecast
3rd DOWN Forecast
4th DOWN Forecast
 
DBVTF Forecast2025
4th UP Forecast
3rd UP Forecast
2nd UP Forecast
1st UP Forecast
1st DOWN Forecast
2nd DOWN Forecast
3rd DOWN Forecast
4th DOWN Forecast
 
DBV Technologies S.A ( OTCGREY USA Symbol : DBVTF )
Sector : N/A And Other Stocks in Same Sector
 
DBVTF Other Details
Segment EQ
Market Capital 136549088.00
Sector
Industry
Offical website >
 
DBVTF Address
DBVTF
 
DBVTF Latest News
 
Your Comments and Response on DBV Technologies S.A
 
DBVTF Business Profile
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents, and adults. The company is also developing Viaskin Milk that is in Phase I/II clinical trial for the treatment of Immunoglobulin E (IgE) mediated cow's milk protein allergy (CMPA) and milk-induced eosinophilic esophagitis; Viaskin Egg, a pre-clinical stage product for the treatment of hen's egg allergy; and booster vaccine for Bordetella pertussis. Its other earlier stage research programs include a vaccine for the respiratory syncytial virus, as well as treatments for Crohn's disease, celiac disease, and type I diabetes. The company has a collaboration with Nestlé Health Science to develop MAG1C, a ready-to-use atopy patch test for the diagnosis of non-IgE mediated CMPA in infants and toddlers. DBV Technologies S.A. was founded in 2002 and is headquartered in Montrouge, France. Address: 177-181 Avenue Pierre Brossolette, Montrouge, France, 92120
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service